Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Interest Expenses (2023 - 2025)

Biofrontera has reported Interest Expenses over the past 3 years, most recently at $120000.0 for Q1 2025.

  • For Q1 2025, Interest Expenses fell 91.56% year-over-year to $120000.0; the TTM value through Dec 2025 reached $120000.0, down 91.92%, while the annual FY2024 figure was $2.1 million, 857.27% up from the prior year.
  • Interest Expenses for Q1 2025 was $120000.0 at Biofrontera, up from $55000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.4 million in Q1 2024 and troughed at $9000.0 in Q3 2024.
  • A 3-year average of $298500.0 and a median of $87500.0 in 2024 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: plummeted 61.54% in 2024 and later plummeted 91.56% in 2025.
  • Year by year, Interest Expenses stood at $143000.0 in 2023, then plummeted by 61.54% to $55000.0 in 2024, then surged by 118.18% to $120000.0 in 2025.
  • Business Quant data shows Interest Expenses for BFRI at $120000.0 in Q1 2025, $55000.0 in Q4 2024, and $9000.0 in Q3 2024.